Global Cancer Supportive Care Therapeutics Market to 2022 - Patent Expirations Create Opportunities for Biosimilars in the Chemotherapy Induced Anemia and Neutropenia Markets - Product Thumbnail Image

Global Cancer Supportive Care Therapeutics Market to 2022 - Patent Expirations Create Opportunities for Biosimilars in the Chemotherapy Induced Anemia and Neutropenia Markets

  • Report
  • 126 Pages
From
Hepatitis A Virus Cellular Receptor 2 (T Cell Immunoglobulin And Mucin Domain Containing Protein 3 or T Cell Immunoglobulin Mucin Receptor 3 or T Cell Membrane Protein 3 or CD366 or HAVCR2) - Pipeline Review, H1 2018 - Product Thumbnail Image

Hepatitis A Virus Cellular Receptor 2 (T Cell Immunoglobulin And Mucin Domain Containing Protein 3 or T Cell Immunoglobulin Mucin Receptor 3 or T Cell Membrane Protein 3 or CD366 or HAVCR2) - Pipeline Review, H1 2018

  • Report
  • 63 Pages
From
Hepatitis A Virus Cellular Receptor 2 (T Cell Immunoglobulin And Mucin Domain Containing Protein 3 or T Cell Immunoglobulin Mucin Receptor 3 or T Cell Membrane Protein 3 or CD366 or HAVCR2) - Pipeline Review, H2 2017 - Product Thumbnail Image

Hepatitis A Virus Cellular Receptor 2 (T Cell Immunoglobulin And Mucin Domain Containing Protein 3 or T Cell Immunoglobulin Mucin Receptor 3 or T Cell Membrane Protein 3 or CD366 or HAVCR2) - Pipeline Review, H2 2017

  • Report
  • 54 Pages
From
Hepatitis A Virus Cellular Receptor 2 (T Cell Immunoglobulin And Mucin Domain Containing Protein 3 or T Cell Immunoglobulin Mucin Receptor 3 or T Cell Membrane Protein 3 or CD366 or HAVCR2) - Pipeline Review, H1 2017 - Product Thumbnail Image

Hepatitis A Virus Cellular Receptor 2 (T Cell Immunoglobulin And Mucin Domain Containing Protein 3 or T Cell Immunoglobulin Mucin Receptor 3 or T Cell Membrane Protein 3 or CD366 or HAVCR2) - Pipeline Review, H1 2017

  • Report
  • 49 Pages
From
Chemotherapy Induced Nausea and Vomiting Global Clinical Trials Review, H1, 2017 - Product Thumbnail Image

Chemotherapy Induced Nausea and Vomiting Global Clinical Trials Review, H1, 2017

  • Clinical Trials
  • 282 Pages
From
Immune Checkpoint Inhibitors: Clinical Trial Tracker - Product Thumbnail Image

Immune Checkpoint Inhibitors: Clinical Trial Tracker

  • Clinical Trials
From
Breast Cancer Therapeutics in Asia-Pacific Markets to 2021 - Growth Driven by Increasing Uptake of Premium Priced Biologics and Rising Prevalence - Product Thumbnail Image

Breast Cancer Therapeutics in Asia-Pacific Markets to 2021 - Growth Driven by Increasing Uptake of Premium Priced Biologics and Rising Prevalence

  • Report
  • 171 Pages
From
Breast Cancer Therapeutics in Major Developed Markets to 2021 - Growth Driven by Rapid Uptake of Premium Priced Biologics and Rising Incidence - Product Thumbnail Image

Breast Cancer Therapeutics in Major Developed Markets to 2021 - Growth Driven by Rapid Uptake of Premium Priced Biologics and Rising Incidence

  • Report
  • 170 Pages
From
Non-Small Cell Lung Cancer Global Clinical Trials Review, H1, 2018 - Product Thumbnail Image

Non-Small Cell Lung Cancer Global Clinical Trials Review, H1, 2018

  • Clinical Trials
  • 3085 Pages
From
 What's Trending in Monoclonal Antibodies (Market by Structure [Chimeric, Humanized], by Target [EGFR, TNF, HER2, CD20,PD-1, Other] and by Disease [Autoimmune, Oncology, Neurological, Other]) - Product Thumbnail Image

What's Trending in Monoclonal Antibodies (Market by Structure [Chimeric, Humanized], by Target [EGFR, TNF, HER2, CD20,PD-1, Other] and by Disease [Autoimmune, Oncology, Neurological, Other])

  • Report
  • 203 Pages
From
Programmed Cell Death Protein 1 (CD279 or Systemic Lupus Erythematosus Susceptibility 2 or PD1) - Pipeline Review, H1 2016 - Product Thumbnail Image

Programmed Cell Death Protein 1 (CD279 or Systemic Lupus Erythematosus Susceptibility 2 or PD1) - Pipeline Review, H1 2016

  • Report
  • 181 Pages
From
Netupitant-Palonosetron FDC Market - Global Opportunity Analysis and Industry Forecast, 2014-2022 - Product Thumbnail Image

Netupitant-Palonosetron FDC Market - Global Opportunity Analysis and Industry Forecast, 2014-2022

  • Report
  • 40 Pages
From
Global Chemotherapy-induced Nausea and Vomiting Drugs Market 2017-2021 - Product Thumbnail Image

Global Chemotherapy-induced Nausea and Vomiting Drugs Market 2017-2021

  • Report
  • 77 Pages
From
Tesaro's Rolapitant: Competition for Emend - Product Thumbnail Image

Tesaro's Rolapitant: Competition for Emend

  • Report
  • 26 Pages
From
Global Chemotherapy Induced Nausea & Vomiting (CINV) Market: Size, Trends & Forecasts (2016-2020) - Product Thumbnail Image

Global Chemotherapy Induced Nausea & Vomiting (CINV) Market: Size, Trends & Forecasts (2016-2020)

  • Report
  • 68 Pages
From
Bispecific Antibody Therapeutics Market (3rd Edition), 2017-2030 - Product Thumbnail Image

Bispecific Antibody Therapeutics Market (3rd Edition), 2017-2030

  • Report
  • 347 Pages
From
Cancer Stem Cell Therapies Market, 2017-2030 - Product Thumbnail Image

Cancer Stem Cell Therapies Market, 2017-2030

  • Report
  • 270 Pages
From
DNA Repair Drugs: Focus on PARP Inhibitors, 2016-2026 - Product Thumbnail Image

DNA Repair Drugs: Focus on PARP Inhibitors, 2016-2026

  • Report
  • 284 Pages
From
Immune Checkpoint Inhibitors Market (2nd edition), 2015-2025 - Product Thumbnail Image

Immune Checkpoint Inhibitors Market (2nd edition), 2015-2025

  • Report
  • 401 Pages
From
Global Cancer Supportive Care Market 2017-2021 - Product Thumbnail Image

Global Cancer Supportive Care Market 2017-2021

  • Report
  • 96 Pages
From
Loading Indicator
adroll